Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study.
Lawrence J, Hullsiek KH, Thackeray LM, Abrams DI, Crane LR, Mayers DL, Jones MC, Saldanha JM, Schmetter BS, Baxter JD. Lawrence J, et al. Among authors: hullsiek kh. J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):169-78. doi: 10.1097/01.qai.0000242450.74779.ee. J Acquir Immune Defic Syndr. 2006. PMID: 16951642 Clinical Trial.
Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus.
Lawrence J, Mayers DL, Hullsiek KH, Collins G, Abrams DI, Reisler RB, Crane LR, Schmetter BS, Dionne TJ, Saldanha JM, Jones MC, Baxter JD; 064 Study Team of the Terry Beirn Community Programs for Clinical Research on AIDS. Lawrence J, et al. Among authors: hullsiek kh. N Engl J Med. 2003 Aug 28;349(9):837-46. doi: 10.1056/NEJMoa035103. N Engl J Med. 2003. PMID: 12944569 Free article. Clinical Trial.
Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.
van den Berg-Wolf M, Hullsiek KH, Peng G, Kozal MJ, Novak RM, Chen L, Crane LR, Macarthur RD; CPCRA 058 Study Team, the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA), and The International Network for Strategic Initiative in Global HIV Trials (INSIGHT). van den Berg-Wolf M, et al. Among authors: hullsiek kh. HIV Clin Trials. 2008 Sep-Oct;9(5):324-36. doi: 10.1310/hct0905-324. HIV Clin Trials. 2008. PMID: 18977721 Clinical Trial.
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
MacArthur RD, Novak RM, Peng G, Chen L, Xiang Y, Hullsiek KH, Kozal MJ, van den Berg-Wolf M, Henely C, Schmetter B, Dehlinger M; CPCRA 058 Study Team; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). MacArthur RD, et al. Among authors: hullsiek kh. Lancet. 2006 Dec 16;368(9553):2125-35. doi: 10.1016/S0140-6736(06)69861-9. Lancet. 2006. PMID: 17174704 Clinical Trial.
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies.
Kozal MJ, Hullsiek KH, Macarthur RD, Berg-Wolf Mv, Peng G, Xiang Y, Baxter JD, Uy J, Telzak EE, Novak RM; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Kozal MJ, et al. Among authors: hullsiek kh. HIV Clin Trials. 2007 Nov-Dec;8(6):357-70. doi: 10.1310/hct0806-357. HIV Clin Trials. 2007. PMID: 18042501 Clinical Trial.
Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, Baxter JD, Huang C, Lubeski C, Turenchalk GS, Braverman MS, Desany B, Rothberg JM, Egholm M, Kozal MJ; Terry Beirn Community Programs for Clinical Research on AIDS. Simen BB, et al. Among authors: hullsiek kh. J Infect Dis. 2009 Mar 1;199(5):693-701. doi: 10.1086/596736. J Infect Dis. 2009. PMID: 19210162 Clinical Trial.
Elevated CD8 counts during HAART are associated with HIV virologic treatment failure.
Krantz EM, Hullsiek KH, Okulicz JF, Weintrob AC, Agan BK, Crum-Cianflone NF, Ganesan A, Ferguson TM, Hale BR; Infectious Disease Clinical Research Program HIV Working Group. Krantz EM, et al. Among authors: hullsiek kh. J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):396-403. doi: 10.1097/QAI.0b013e318221c62a. J Acquir Immune Defic Syndr. 2011. PMID: 21602694 Free PMC article.
Untreated HIV infection and large and small artery elasticity.
Baker JV, Duprez D, Rapkin J, Hullsiek KH, Quick H, Grimm R, Neaton JD, Henry K. Baker JV, et al. Among authors: hullsiek kh. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):25-31. doi: 10.1097/qai.0b013e3181b02e6a. J Acquir Immune Defic Syndr. 2009. PMID: 19731451 Free PMC article.
95 results